Dr. Merih Tepeoglu, Turkey Oral
Guardian of renal harmony: Unraveling the ıntricacies of CD47 expression in allograft rejection and graft survival

Dr. Bingxuan Zheng, People's Republic of China Oral
Blocking CXCL10-CXCR3-mediated macrophages can reduce the antibody-mediated rejection of renal transplantation

Dr. Dhakshayini Tharmaraj, Australia Oral
Intragraft gene transcript changes with intravenous immunoglobulin therapy versus standard care in chronic antibody mediated rejection- vipar study cohort

Mrs. Cristina Glehn, Brazil Oral
Anti-HLA Donor-Specific Antibody Pretransplant Assessment Impact on Long-Term Outcomes After Kidney Transplantation

Dr. Gillian Divard, France Oral
Effectiveness of the Treatment of Antibody Mediated Rejection- a Real-World evidence study

Dr. Aylin Akifova, Germany Oral
Absolute dd-cfDNA monitoring reduces time to ABMR diagnosis in kidney transplant recipients with de novo DSA: a diagnostic randomized clinical trial

Prof. Binnaz Handan Ozdemir, Turkey Oral
Unexpected role of programmed death-ligand 1 (PD-L1) in renal allografts with antibody-mediated rejection

Dr. Eda Yilmaz Akcay, Turkey Oral
Correlation of early ultrastructural findings, microvascular HLA-DR, and VEGF expression in renal allografts with acute rejection types: Impact on transplant glomerulopathy and interstitial fibrosis

Dr. Aravind Cherukuri, United States Oral
The Clinical Utility of Follow-up Allograft Biopsies After Early Acute TCMR In Renal Transplantation